Immucell Corp (ICCC) Reports Q3 EPS of $0.09

Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of $0.09, versus $0.04 reported last year. Revenue for the quarter came in at $2.7 million, versus $2.21 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c